{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:52:34Z","timestamp":1791647554472,"version":"4.3.4"},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T00:00:00Z","timestamp":1746403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100015693","name":"Research Institute for Gastroenterology and Liver Diseases","doi-asserted-by":"publisher","award":["IR.SBMU.RIGLD.REC.1399.054"],"award-info":[{"award-number":["IR.SBMU.RIGLD.REC.1399.054"]}],"id":[{"id":"10.13039\/501100015693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background and Aims<\/jats:title>\n<jats:p>Primary sclerosing cholangitis (PSC) exhibits varying incidence and prevalence rates across different regions; however, comprehensive global studies examining its geographic distribution and future trends are scarce. This study presents an updated meta-analysis through 2024 and projects the global and regional prevalence of PSC from 2024 to 2040 using an illness-death multi-state model.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>We conducted a thorough systematic search across multiple databases to identify all primary studies published until 2024 that reported on the incidence, prevalence, and mortality rates of PSC in various regions. Using the gathered data, we developed an illness-death model to forecast the future prevalence of PSC, covering the years 2024\u20132040.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Our meta-analysis revealed that the global pooled incidence and prevalence rates of PSC are 0.65 and 7.52 per 100,000 persons, respectively. Projections indicate that the global prevalence of PSC will rise to 22.98 cases per 100,000 (95% CI: 21.0\u201324.95), corresponding to an overall increase of 28.3%. Specifically, North America is forecasted to experience a 5.45% increase in PSC cases, reaching 24.76 cases per 100,000 (95% CI: 19.63\u201329.88), while Western Europe is anticipated to see a more pronounced rise of 28.79%, resulting in a prevalence of 21.48 cases per 100,000 (95% CI: 18.3\u201324.65) by 2040.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Our findings indicate a substantial rise in the number of individuals affected by PSC in recent years and estimate a significant future burden of the disease.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0322479","type":"journal-article","created":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T17:26:12Z","timestamp":1746465972000},"page":"e0322479","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["The epidemiological trends and projected future of primary sclerosing cholangitis by 2040: An updated meta-analysis and modeling study"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5011-1380","authenticated-orcid":true,"given":"Meysam","family":"Olfatifar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Rajabnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhassan","family":"Rabbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabnam","family":"Shahrokh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Amin","family":"Habibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MehdiSure","family":"Pezeshgi Modarres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6813-0229","authenticated-orcid":true,"given":"Hamidreza","family":"Houri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,5,5]]},"reference":[{"issue":"8","key":"pone.0322479.ref001","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"MH Chapman","year":"2019","journal-title":"Gut"},{"issue":"3","key":"pone.0322479.ref002","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/apt.12581","article-title":"Review article: controversies in the management of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"TH Karlsen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"pone.0322479.ref003","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/gut.2004.046615","article-title":"PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"54","author":"Jr Loftus EV","year":"2005","journal-title":"Gut"},{"issue":"6","key":"pone.0322479.ref004","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"AB de Vries","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"4","key":"pone.0322479.ref005","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.51.4.567","article-title":"Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study","volume":"51","author":"SA Mitchell","year":"2002","journal-title":"Gut"},{"issue":"01","key":"pone.0322479.ref006","first-page":"003-21","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"CA O\u2019Mahony","year":"2006","journal-title":"Semin Liver Dis"},{"issue":"5","key":"pone.0322479.ref007","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"American College of Gastroenterology","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"pone.0322479.ref008","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1136\/gutjnl-2020-322362","article-title":"Recent advances in clinical practice: epidemiology of autoimmune liver diseases","volume":"70","author":"PJ Trivedi","year":"2021","journal-title":"Gut"},{"issue":"10","key":"pone.0322479.ref009","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1111\/liv.15007","article-title":"Global incidence, prevalence and features of primary sclerosing cholangitis: A systematic review and meta-analysis","volume":"41","author":"TI Mehta","year":"2021","journal-title":"Liver Int"},{"issue":"5","key":"pone.0322479.ref010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrgastro.2016.154","article-title":"Genetics of primary sclerosing cholangitis and pathophysiological implications","volume":"14","author":"X Jiang","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"pone.0322479.ref011","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1002\/hep.26565","article-title":"Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis","volume":"58","author":"K Boonstra","year":"2013","journal-title":"Hepatology"},{"issue":"1","key":"pone.0322479.ref012","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: A single center study","volume":"102","author":"JJW Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"pone.0322479.ref013","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"GG Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"7","key":"pone.0322479.ref014","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"D Moher","year":"2009","journal-title":"PLoS Med"},{"key":"pone.0322479.ref015","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.tpb.2017.11.006","article-title":"Projections of health indicators for chronic disease under a semi-Markov assumption","volume":"119","author":"M Wanneveich","year":"2018","journal-title":"Theor Popul Biol"},{"issue":"1","key":"pone.0322479.ref016","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1541-0420.2012.01827.x","article-title":"Prevalence projections of chronic diseases and impact of public health intervention","volume":"69","author":"P Joly","year":"2013","journal-title":"Biometrics"},{"key":"pone.0322479.ref017","volume-title":"Institute for Health Metrics and Evaluation (IHME)","author":"Metrics IfH, Evaluation.","year":"2018"},{"issue":"1","key":"pone.0322479.ref018","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12876-021-01745-1","article-title":"The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study","volume":"21","author":"M Olfatifar","year":"2021","journal-title":"BMC Gastroenterol"},{"key":"pone.0322479.ref019","volume-title":"A limited-memory algorithm for bound-constrained opttmization","author":"H. Richard","year":"2008"},{"issue":"8","key":"pone.0322479.ref020","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.cgh.2021.08.039","article-title":"Epidemiology, natural history, and outcomes of primary sclerosing cholangitis: a systematic review of population-based studies","volume":"20","author":"PJ Trivedi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"pone.0322479.ref021","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"K Boonstra","year":"2012","journal-title":"J Hepatol"},{"issue":"7","key":"pone.0322479.ref022","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41575-018-0003-z","article-title":"Urbanization and the gut microbiota in health and inflammatory bowel disease","volume":"15","author":"T Zuo","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"24","key":"pone.0322479.ref023","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1007\/s00018-016-2311-1","article-title":"Environmental factors in autoimmune diseases and their role in multiple sclerosis","volume":"73","author":"S J\u00f6rg","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"pone.0322479.ref024","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jclinepi.2019.10.011","article-title":"Excluding non-English publications from evidence-syntheses did not change conclusions: a meta-epidemiological study","volume":"118","author":"B Nussbaumer-Streit","year":"2020","journal-title":"J Clin Epidemiol"},{"issue":"5","key":"pone.0322479.ref025","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver","volume":"21","author":"A Escorsell","year":"1994","journal-title":"J Hepatol"},{"issue":"4","key":"pone.0322479.ref026","first-page":"813","article-title":"Clinical hepatology: profile of an urban, hospital-based practice","volume":"24","author":"D Byron","year":"1996","journal-title":"Hepatology"},{"issue":"29","key":"pone.0322479.ref027","first-page":"4517","article-title":"Incidence and prevalence of autoimmune liver diseases","volume":"118","author":"JE Berdal","year":"1998","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"1","key":"pone.0322479.ref028","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"KM Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"pone.0322479.ref029","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","article-title":"Clinical profile of primary sclerosing cholangitis in Singapore","volume":"17","author":"TL Ang","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"issue":"5","key":"pone.0322479.ref030","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"K Bambha","year":"2003","journal-title":"Gastroenterology"},{"issue":"7","key":"pone.0322479.ref031","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"JGC Kingham","year":"2004","journal-title":"Gastroenterology"},{"issue":"6","key":"pone.0322479.ref032","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.jhep.2008.02.017","article-title":"Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study","volume":"48","author":"TR Card","year":"2008","journal-title":"J Hepatol"},{"issue":"2","key":"pone.0322479.ref033","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/hep.23678","article-title":"Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden","volume":"52","author":"B Lindkvist","year":"2010","journal-title":"Hepatology"},{"issue":"12","key":"pone.0322479.ref034","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.cgh.2011.08.027","article-title":"Inflammatory bowel disease is associated with poor outcomes of patients with primary sclerosing cholangitis","volume":"9","author":"JH Ngu","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"pone.0322479.ref035","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1471-230X-11-83","article-title":"The prevalence, incidence and natural history of primary sclerosing cholangitis in an ethnically diverse population","volume":"11","author":"E Toy","year":"2011","journal-title":"BMC Gastroenterol"},{"issue":"2","key":"pone.0322479.ref036","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/ecco-jcc\/jju013","article-title":"Prognosis of primary sclerosing cholangitis in israel is independent of coexisting inflammatory bowel Disease","volume":"9","author":"H Yanai","year":"2015","journal-title":"J Crohns Colitis"},{"issue":"3","key":"pone.0322479.ref037","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/liv.13328","article-title":"Epidemiology and outcomes of primary sclerosing cholangitis with and without inflammatory bowel disease in an Australian cohort","volume":"37","author":"K Liu","year":"2017","journal-title":"Liver Int"},{"issue":"24","key":"pone.0322479.ref038","doi-asserted-by":"crossref","first-page":"e7116","DOI":"10.1097\/MD.0000000000007116","article-title":"Incidence, prevalence, and natural history of primary sclerosing cholangitis in the United Kingdom","volume":"96","author":"H Liang","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"pone.0322479.ref039","first-page":"371","article-title":"[Primary sclerosing cholangitis in Iceland 1992-2012].","volume":"105","author":"HO Gudnason","year":"2019","journal-title":"Laeknabladid"},{"issue":"8","key":"pone.0322479.ref040","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/hepr.13342","article-title":"Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis in Japan","volume":"49","author":"A Tanaka","year":"2019","journal-title":"Hepatol Res"},{"issue":"1","key":"pone.0322479.ref041","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365521.2019.1707277","article-title":"Epidemiology, risk of malignancy and patient survival in primary sclerosing cholangitis: a population-based study in Finland","volume":"55","author":"N Barner-Rasmussen","year":"2020","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"pone.0322479.ref042","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/ijerph17093095","article-title":"Primary sclerosing cholangitis: burden of disease and mortality using data from the national rare diseases registry in Italy","volume":"17","author":"M Carbone","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"pone.0322479.ref043","doi-asserted-by":"crossref","first-page":"100202","DOI":"10.1016\/j.jhepr.2020.100202","article-title":"Geo-epidemiology and environmental co-variate mapping of primary biliary cholangitis and primary sclerosing cholangitis","volume":"3","author":"JK Dyson","year":"2020","journal-title":"JHEP Rep"},{"issue":"5","key":"pone.0322479.ref044","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00535-020-01663-1","article-title":"An update on primary sclerosing cholangitis epidemiology, outcomes and quantification of alkaline phosphatase variability in a population-based cohort","volume":"55","author":"Z Bakhshi","year":"2020","journal-title":"J Gastroenterol"},{"issue":"4","key":"pone.0322479.ref045","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/hep.26454","article-title":"Primary sclerosing cholangitis, autoimmune hepatitis, and overlap in Utah children: epidemiology and natural history","volume":"58","author":"M Deneau","year":"2013","journal-title":"Hepatology"},{"issue":"3","key":"pone.0322479.ref046","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.cgh.2020.05.061","article-title":"Trends in incidence of autoimmune liver diseases and increasing incidence of autoimmune hepatitis","volume":"19","author":"M Lamba","year":"2021","journal-title":"Clin.\u00a0Gastroenterol.\u00a0Hepatol"},{"issue":"5","key":"pone.0322479.ref047","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s12072-022-10356-1","article-title":"Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study","volume":"16","author":"N Tan","year":"2022","journal-title":"Hepatol Int"},{"issue":"1","key":"pone.0322479.ref048","first-page":"2","article-title":"P32 evaluating the natural history of primary sclerosing cholangitis (PSC): a Canadian population-based study.","volume":"6","author":"H Patel","year":"2023","journal-title":"Can Liv J"},{"issue":"1","key":"pone.0322479.ref049","doi-asserted-by":"crossref","first-page":"2221368","DOI":"10.1080\/22423982.2023.2221368","article-title":"A nationwide study of autoimmune liver diseases in the Faroe Islands: Incidence, prevalence, and causes of death 2004 - 2021","volume":"82","author":"KR Nielsen","year":"2023","journal-title":"Int J Circumpolar Health"},{"key":"pone.0322479.ref050","doi-asserted-by":"crossref","first-page":"103264","DOI":"10.1016\/j.jaut.2024.103264","article-title":"Prevalence and clinical profiles of primary sclerosing cholangitis in China: Data from electronic medical records and systematic literature retrieval","volume":"147","author":"X Xu","year":"2024","journal-title":"J Autoimmun"},{"issue":"1","key":"pone.0322479.ref051","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13023-024-03086-0","article-title":"Epidemiology of autoimmune liver disease in Korea: evidence from a nationwide real-world database","volume":"19","author":"J Lim","year":"2024","journal-title":"Orphanet J Rare Dis"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0322479","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T17:26:23Z","timestamp":1746465983000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0322479"}},"subtitle":[],"editor":[{"given":"Maher Abdelraheim","family":"Titi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,5,5]]},"references-count":51,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0322479","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,5]]}}}